Latest Diabetic retinopathy Stories

2014-02-10 08:26:04

TARRYTOWN, N.Y., Feb. 10, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that in the Phase 3 VISTA-DME trial of EYLEA(®) (aflibercept) Injection for the treatment of diabetic macular edema (DME), EYLEA 2 milligrams (mg) dosed monthly (2Q4) and EYLEA 2 mg dosed every two months (after 5 initial monthly injections, 2Q8) showed a sustained improvement from baseline in best corrected visual acuity (BCVA) at week 100, compared to...

2014-02-05 12:28:59

DR. CATHERINE PHAM JOINS HAWAII CATARACT & LASER INSTITUTE KAHULUI, Hawaii, Feb. 5, 2014 /PRNewswire/ -- Hawaii Cataract and Laser Institute's Maui location is pleased to announce Catherine Pham, MD will be joining its Kahului office beginning February 10, 2014. Dr. Pham's arrival to this office opens new opportunities to provide patients with comprehensive eye care without the delay of an appointment. (Photo: http://photos.prnewswire.com/prnh/20140205/LA59337) A board-certified...

2014-01-13 08:26:25

First NHS patient treated less than seven weeks following NICE published guidance ATLANTA, Jan. 13, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has begun shipping initial orders of ILUVIEN® to several United Kingdom National Health Service (NHS) facilities. Additionally, on January 10, 2014, the...

Word of the Day
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.